SEARCH

SEARCH BY CITATION

References

  • 1
    Williams, K. A. and Coster, D. J., The immunobiology of corneal transplantation. Transplantation 2007. 84: 806813.
  • 2
    Fu, H., Larkin, D. F. and George, A. J., Immune modulation in corneal transplantation. Transplant. Rev. (Orlando) 2008. 22: 105115.
  • 3
    Barker, C. F. and Billingham, R. E., Immunologically privileged sites. Adv. Immunol. 1977. 25: 154.
  • 4
    Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R. and Ferguson, T. A., Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995. 270: 11891192.
  • 5
    Streilein, J. W., Toews, G. B. and Bergstresser, P. R., Corneal allografts fail to express Ia antigens. Nature 1979. 282: 326327.
  • 6
    Wang, H. M., Kaplan, H. J., Chan, W. C. and Johnson, M., The distribution and ontogeny of MHC antigens in murine ocular tissue. Invest. Ophthalmol. Vis. Sci. 1987. 28: 13831389.
  • 7
    Forrester, J. V., Xu, H., Kuffova, L., Dick, A. D. and McMenamin, P. G., Dendritic cell physiology and function in the eye. Immunol. Rev. 2010. 234: 282304.
  • 8
    Stein-Streilein, J. and Streilein, J. W., Anterior chamber associated immune deviation (ACAID): regulation, biological relevance, and implications for therapy. Int. Rev. Immunol. 2002. 21: 123152.
  • 9
    Niederkorn, J. Y. and Larkin, D. F., Immune privilege of corneal allografts. Ocul. Immunol. Inflamm. 2010. 18: 162171.
  • 10
    Bernard, A. C., Mistry, S. K., Morris, S. M., Jr., O'Brien, W. E., Tsuei, B. J., Maley, M. E., Shirley, L. A. et al., Alterations in arginine metabolic enzymes in trauma. Shock 2001. 15: 215219.
  • 11
    Wu, G. and Morris, S. M., Jr., Arginine metabolism: nitric oxide and beyond. Biochem. J. 1998. 336: 117.
  • 12
    Hibbs, J. B., Jr., Taintor, R. R. and Vavrin, Z., Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 1987. 235: 473476.
  • 13
    Jenkinson, C. P., Grody, W. W. and Cederbaum, S. D., Comparative properties of arginases. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 1996. 114: 107132.
  • 14
    Rodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A. et al., Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res. 2004. 64: 58395849.
  • 15
    Rodriguez, P. C., Ernstoff, M. S., Hernandez, C., Atkins, M., Zabaleta, J., Sierra, R. and Ochoa, A. C., Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 2009. 69: 15531560.
  • 16
    Munder, M., Schneider, H., Luckner, C., Giese, T., Langhans, C. D., Fuentes, J. M., Kropf, P. et al., Suppression of T-cell functions by human granulocyte arginase. Blood 2006. 108: 16271634.
  • 17
    Kropf, P., Baud, D., Marshall, S. E., Munder, M., Mosley, A., Fuentes, J. M., Bangham, C. R. et al., Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy. Eur. J. Immunol. 2007. 37: 935945.
  • 18
    Munder, M., Eichmann, K. and Modolell, M., Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J. Immunol. 1998. 160: 53475354.
  • 19
    Iyer, R. K., Yoo, P. K., Kern, R. M., Rozengurt, N., Tsoa, R., O'Brien, W. E., Yu, H. et al., Mouse model for human arginase deficiency. Mol. Cell. Biol. 2002. 22: 44914498.
  • 20
    Jeyabalan, G., Klune, J. R., Nakao, A., Martik, N., Wu, G., Tsung, A. and Geller, D. A., Arginase blockade protects against hepatic damage in warm ischemia-reperfusion. Nitric Oxide 2008. 19: 2935.
  • 21
    King, W. J., Comer, R. M., Hudde, T., Larkin, D. F. and George, A. J., Cytokine and chemokine expression kinetics after corneal transplantation. Transplantation 2000. 70: 12251233.
  • 22
    Sagoo, P., Chan, G., Larkin, D. F. and George, A. J., Inflammatory cytokines induce apoptosis of corneal endothelium through nitric oxide. Invest. Ophthalmol. Vis. Sci. 2004. 45: 39643973.
  • 23
    Bradley, B. A., Vail, A., Gore, S. M., Rogers, C. A., Armitage, W. J., Nicholls, S. M. and Easty, D. L., Penetrating keratoplasty in the United Kingdom: an interim analysis of the corneal transplant follow-up study. Clin. Transplant. 1993. 293315.
  • 24
    Hooper, P., Bora, N. S., Kaplan, H. J. and Ferguson, T. A., Inhibition of lymphocyte proliferation by resident ocular cells. Curr. Eye Res. 1991. 10: 363372.
  • 25
    Wilbanks, G. A. and Streilein, J. W., Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta. Eur. J. Immunol. 1992. 22: 10311036.
  • 26
    Yu, H., Yoo, P. K., Aguirre, C. C., Tsoa, R. W., Kern, R. M., Grody, W. W., Cederbaum, S. D. and Iyer, R. K., Widespread expression of arginase I in mouse tissues. Biochemical and physiological implications. J. Histochem. Cytochem. 2003. 51: 11511160.
  • 27
    Rodriguez, P. C., Zea, A. H., Culotta, K. S., Zabaleta, J., Ochoa, J. B. and Ochoa, A. C., Regulation of T cell receptor CD3zeta chain expression by L-arginine. J. Biol. Chem. 2002. 277: 2112321129.
  • 28
    Mistry, S. K., Zheng, M., Rouse, B. T. and Morris, S. M., Jr., Induction of arginases I and II in cornea during herpes simplex virus infection. Virus Res. 2001. 73: 177182.
  • 29
    Holan, V., Pindjakova, J., Krulova, M., Neuwirth, A., Fric, J. and Zajicova, A., Production of nitric oxide during graft rejection is regulated by the Th1/Th2 balance, the arginase activity, and L-arginine metabolism. Transplantation 2006. 81: 17081715.
  • 30
    Debats, I. B., Wolfs, T. G., Gotoh, T., Cleutjens, J. P., Peutz-Kootstra, C. J. and van der Hulst, R. R., Role of arginine in superficial wound healing in man. Nitric Oxide 2009. 21: 175183.
  • 31
    Sugioka, A., Morita, M., Fujita, J., Hasumi, A. and Shiroishi, T., Graft acceptance and tolerance induction in mouse liver transplantation using wild mice. Transplant. Proc. 2001. 33: 137139.
  • 32
    Qian, S., Demetris, A. J., Murase, N., Rao, A. S., Fung, J. J. and Starzl, T. E., Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 1994. 19: 916924.
  • 33
    Chicoine, L. G., Paffett, M. L., Young, T. L. and Nelin, L. D., Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2004. 287: L60L68.
  • 34
    Li, H., Meininger, C. J., Hawker, J. R., Jr., Haynes, T. E., Kepka-Lenhart, D., Mistry, S. K., Morris, S. M., Jr. and Wu, G., Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am. J. Physiol. Endocrinol. Metab. 2001. 280: E75E82.
  • 35
    Fligger, J., Blum, J. and Jungi, T. W., Induction of intracellular arginase activity does not diminish the capacity of macrophages to produce nitric oxide in vitro. Immunobiology 1999. 200: 169186.
  • 36
    Cobbold, S. P., Adams, E., Farquhar, C. A., Nolan, K. F., Howie, D., Lui, K. O., Fairchild, P. J. et al., Infectious tolerance via the consumption of essential amino acids and mTOR signaling. Proc. Natl. Acad. Sci. USA 2009. 106: 1205512060.
  • 37
    Mellor, A. L. and Munn, D. H., IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 2004. 4: 762774.
  • 38
    Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C. and Mellor, A. L., Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998. 281: 11911193.
  • 39
    Beutelspacher, S. C., Pillai, R., Watson, M. P., Tan, P. H., Tsang, J., McClure, M. O., George, A. J. and Larkin, D. F., Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur. J. Immunol. 2006. 36: 690700.
  • 40
    Niederkorn, J. Y., Chiang, E. Y., Ungchusri, T. and Stroynowski, I., Expression of a nonclassical MHC class Ib molecule in the eye. Transplantation 1999. 68: 17901799.
  • 41
    Yang, M., Rangasamy, D., Matthaei, K. I., Frew, A. J., Zimmmermann, N., Mahalingam, S., Webb, D. C. et al., Inhibition of arginase I activity by RNA interference attenuates IL-13-induced airways hyperresponsiveness. J. Immunol. 2006. 177: 55955603.
  • 42
    Kropf, P., Fuentes, J. M., Fahnrich, E., Arpa, L., Herath, S., Weber, V., Soler, G. et al., Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. FASEB J. 2005. 19: 10001002.
  • 43
    Braun, M. Y., Grandjean, I., Feunou, P., Duban, L., Kiss, R., Goldman, M. and Lantz, O., Acute rejection in the absence of cognate recognition of allograft by T cells. J. Immunol. 2001. 166: 48794883.
  • 44
    Ardjomand, N., McAlister, J. C., Rogers, N. J., Tan, P. H., George, A. J. and Larkin, D. F., Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection. Invest. Ophthalmol. Vis. Sci. 2003. 44: 38993905.
  • 45
    Zhang, E. P., Schrunder, S. and Hoffmann, F., Orthotopic corneal transplantation in the mouse – a new surgical technique with minimal endothelial cell loss. Graefes Arch. Clin. Exp. Ophthalmol. 1996. 234: 714719.
  • 46
    Billingham, R. E., Krohn, P. L. and Medawar, P. B., Effect of locally applied cortisone acetate on survival of skin homografts in rabbits. Br. Med. J. 1951. 2: 10491053.